Plasma YKL-40 as a biomarker in patients with nonmetastatic bone and soft tissue sarcomas: a prospective exploratory clinical study

Andrea P. Thorn, Mette L. Harving, Gunnar S. Lausten, Julia S. Johansen, Michala S. Sorensen, Michael M. Petersen

Original languageEnglish
JournalINTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY
Volume5
Issue number3
Pages (from-to)e87
ISSN2471-3864
DOIs
Publication statusPublished - Jun 2020

Keywords

  • YKL-40
  • Prognosis
  • Survival
  • Nonmetastatic bone sarcoma
  • Nonmetastatic soft tissue sarcomas

Cite this